Table 5.
Reported incidence of scapular notching
| Study | Number of patients | Age* (years) | Prosthesis† | Followup* (months) | Number with scapular notching |
|---|---|---|---|---|---|
| Valenti et al. [28] (2001) | 22 | 70 (55–87) | Delta III | 84 (60–108) | 19 (86%) |
| Sirveaux et al. [25] (2001) | 80 | 72 (58–86) | Delta III | 44.5 (24–101) | 50 (65%) |
| Boulahia et al. [2] (2002) | 16 | 77 (66–80) | Delta III | 35 (24–65) | 10 (63%) |
| De Wilde et al. [4] (2003) | 13 | 49 (26–68) | Delta III | 36 (5–120) | 4 (31%) |
| Vanhove and Beugnies [29] (2004) | 14 | 71 (55–85) | Delta III | 31 (11–50) | 7 (50%) |
| Sirveaux et al. [26] (2004) | 80 | 73 (60–86) | Delta III | 44 (24–97) | 49 (64%) |
| Boileau et al. [1] (2005) | 45 | NR | Delta III | 40 (24–72) | 24 (74%) |
| Werner et al. [30] (2005) | 58 | 68 (44–84) | Delta III | 38 (24–NR) | 56 (97%) |
| Frankle et al. [9] (2005) | 60 | 71 (34–86) | Reverse Shoulder Prosthesis | 33 (24–68) | 0 (0%) |
*Values expressed as means, with ranges in parentheses; †prostheses included the Delta III® Reverse Shoulder System (DePuy Orthopaedics, Inc, Warsaw, IN) and the Reverse® Shoulder Prosthesis (Encore Medical, LP, Austin, TX); NR = not reported.